Clinical impact and in vitro characterization of ADNP variants in pediatric patients

Chuanhui Ge,Yuxin Tian,Chunchun Hu,Lianni Mei,Dongyun Li,Ping Dong,Ying Zhang,Huiping Li,Daijing Sun,Wenzhu Peng,Xiu Xu,Yan Jiang,Qiong Xu
DOI: https://doi.org/10.1186/s13229-024-00584-7
2024-01-24
Molecular Autism
Abstract:Helsmoortel–Van der Aa syndrome (HVDAS) is a rare genetic disorder caused by variants in the activity-dependent neuroprotector homeobox ( ADNP ) gene; hence, it is also called ADNP syndrome. ADNP is a multitasking protein with the function as a transcription factor, playing a critical role in brain development. Furthermore, ADNP variants have been identified as one of the most common single-gene causes of autism spectrum disorder (ASD) and intellectual disability.
genetics & heredity,neurosciences
What problem does this paper attempt to address?
The paper attempts to address the issue of exploring the clinical impact and in vitro characteristics of ADNP gene variants in pediatric patients. Specifically, the study aims to: 1. **Describe the clinical manifestations of ADNP gene variants**: By analyzing the clinical phenotypes of 15 Chinese pediatric patients, the study reveals the wide range of symptoms caused by ADNP gene variants, including global developmental delay, intellectual disability, autism spectrum disorder (ASD), facial abnormalities, and more. 2. **Validate the functional impact of ADNP gene variants**: By constructing corresponding ADNP variants and expressing them in HEK293T and SH-SY5Y cells, the study evaluates the impact of these variants on protein expression and subcellular localization. 3. **Explore the specific impact of different types of ADNP variants on protein function**: Particularly, the study investigates how missense variants, nonsense variants, and frameshift variants affect the nuclear localization and function of the ADNP protein. 4. **Establish the relationship between ADNP gene variants and clinical phenotypes**: By categorizing different types of variants (such as epi-ADNP1 and epi-ADNP2), the study explores whether these variants are associated with specific clinical features. In summary, the study aims to comprehensively understand the role of ADNP gene variants in Helsmoortel–Van der Aa syndrome (HVDAS) through clinical and laboratory data, providing a scientific basis for the diagnosis and treatment of this disease.